Risk of active tuberculosis in patients with cancer: a systematic review and metaanalysis
Background. Cancer is a known risk factor for develo** active tuberculosis. We
determined the incidence and relative risk of active tuberculosis in cancer patients …
determined the incidence and relative risk of active tuberculosis in cancer patients …
Pharmacology of dimethanesulfonate alkylating agents: busulfan and treosulfan
A Galaup, A Paci - Expert opinion on drug metabolism & toxicology, 2013 - Taylor & Francis
Introduction: Among the dimethanesulfonates, busulfan, in combination with other alkylating
agents or nucleoside analogues, is the cornerstone of high-dose chemotherapy. It is used …
agents or nucleoside analogues, is the cornerstone of high-dose chemotherapy. It is used …
Cost of treatment of multiple myeloma in a public sector tertiary care hospital of North India
Multiple myeloma (MM) is a neoplastic disorder, which accounts for 13% of all hematological
malignancies globally. While, conventional chemotherapy used to be the mainstay treatment …
malignancies globally. While, conventional chemotherapy used to be the mainstay treatment …
Recent advances in the mangement of multiple myeloma.
L Kumar, P Vikram, V Kochupillai - The National Medical Journal of …, 2006 - europepmc.org
The management of multiple myeloma has undergone a major change during the past
decade. Currently, patients< 65 years of age with advanced disease (stage II-III) are best …
decade. Currently, patients< 65 years of age with advanced disease (stage II-III) are best …
Consensus in the management of multiple myeloma in India at myeloma state of the art 2016 conference
The science of multiple myeloma (MM) and related plasma cell disorders is rapidly evolving
with increased understanding of the disease biology and recent approval of the newer drugs …
with increased understanding of the disease biology and recent approval of the newer drugs …
High-dose chemotherapy with autologous stem cell transplantation for multiple myeloma: what predicts the outcome? Experience from a develo** country
L Kumar, J Ghosh, P Ganessan, A Gupta… - Bone marrow …, 2009 - nature.com
We analyzed the results of 108 patients (78 males and 30 females) with multiple myeloma
who underwent autologous stem cell transplantation (ASCT). The median age of patients …
who underwent autologous stem cell transplantation (ASCT). The median age of patients …
Factors affecting outcome of patients with multiple myeloma
A Basit, N Siddiqui, A Hameed… - Journal of Ayub …, 2014 - jamc.ayubmed.edu.pk
Background: Multiple myeloma is a heterogeneous disease, with wide survival range and
multiple risk factors and staging systems linked to survival. The objective of this study was to …
multiple risk factors and staging systems linked to survival. The objective of this study was to …
Haematopoietic stem cell transplantation: current status.
L Kumar - The National Medical Journal of India, 2007 - europepmc.org
Haematopoietic stem cell transplantation (HSCT) is now an established treatment fora
number of non-malignant and malignant conditions. Bone marrow-or peripheral blood …
number of non-malignant and malignant conditions. Bone marrow-or peripheral blood …
Head and neck manifestations of myeloma in Nigerians
A study on the clinicopathologic features of myeloma as it manifests in the head and neck
region was conducted over a 15-year period. A total of six patients were seen and they …
region was conducted over a 15-year period. A total of six patients were seen and they …
Hematological practice in India
Hematological practice ranges from availability of advanced diagnostic facilities and
treatment to unavailability of basic medical services to rural India. Problems include a huge …
treatment to unavailability of basic medical services to rural India. Problems include a huge …